Article Details

BioNTech Inks $250M Deal with Autolus to Advance CAR T Assets | BioSpace

Retrieved on: 2024-02-08 16:17:54

Tags for this article:

Click the tags to see associated articles and topics

BioNTech Inks $250M Deal with Autolus to Advance CAR T Assets | BioSpace. View article details on hiswai:

Excerpt

... monoclonal antibodies. However, the details of the antibodies' therapeutic target were not revealed at the time. Tyler Patchen is a staff writer ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up